The Department for Promotion of Industry and Internal Trade (DPIIT) has announced the relocation of the CGPDTM headquarters to New Delhi, as per the Gazette of India notification dated February 25, 2025. The new office is now operational at Boudhik Sampada Bhawan, Dwarka, New Delhi. This move aims to enhance coordination with central regulatory bodies and improve India’s intellectual property administration.
Read more about CGPDTM Headquarters Relocated to New Delhi: Official NotificationTag: Patents
Indian Patent & Design Statistics Report – 2025
BananaIP’s Indian Patent and Design Statistics Report 2024 highlights a 60% increase in patent publications, a 15% drop in grants, and reduced examination rates. Delhi and Chennai emerge as top contributors to filings, showcasing trends in India’s evolving IP landscape.
Read more about Indian Patent & Design Statistics Report – 2025Refusal of a patent application based on prior art not cited in hearing notice set aside by the Delhi High Court
In this case the Delhi High Court set aside an order of the Controller of Patents refusing a patent application based on a ground not raised in the hearing notice. The refusal order was set aside as it lacked proper reasoning as required for inventive step analysis.
Read more about Refusal of a patent application based on prior art not cited in hearing notice set aside by the Delhi High CourtInventive Step analysis requires a rigorous examination, not surface analysis, says the Delhi High Court.
In this case the Delhi High Court set aside an order of the Controller of Patents refusing a patent application. The refusal order was set aside as it lacked proper reasoning as required for inventive step analysis.
Read more about Inventive Step analysis requires a rigorous examination, not surface analysis, says the Delhi High Court.Method of producing ‘protein enriched blood serum’ is not a method of treatment under Section 3(i), says the Delhi High Court
Delhi High Court reviewed whether new objections can be raised at the hearing stage of a Patent Application. The Court examined the claims and the refusal order, from the purview of Principles of Natural Justice.
Read more about Method of producing ‘protein enriched blood serum’ is not a method of treatment under Section 3(i), says the Delhi High CourtPatent and Trademark Dispute Settlements
Exploring successful settlements in IP disputes involving Asian Paints, Colorbar, Pfizer, and their counterparts, showcasing effective dispute resolution outside of court.
Read more about Patent and Trademark Dispute SettlementsReversal of unreasoned and invalid Patent refusals based on Section 3(d), Novelty, and Inventive Step
Exploring recent High Court judgments overturning patent application refusals, highlighting the importance of detailed reasoning and thorough consideration in patent office decisions.
Read more about Reversal of unreasoned and invalid Patent refusals based on Section 3(d), Novelty, and Inventive StepIndian Patent and Design Statistics 2024 (January 12th – 19th)
BananaIP Counsels brings to you the Weekly Patent and Design Statistics report from the Official Journal of Patents and Designs for the period of 12th to 19th January, 2024.
Read more about Indian Patent and Design Statistics 2024 (January 12th – 19th)Officer’s Choice Trademark, Zinking Patent and Baoji Footwear Cases
This post highlights recent decisions by the High Court of Delhi and Himachal Pradesh on intellectual property rights, focusing on trademark and patent infringement cases....
Read more about Officer’s Choice Trademark, Zinking Patent and Baoji Footwear CasesIndian Patent Statistics Report – 2023
BananaIP is pleased to release the 2023 Patent Statistics Report. This document offers a comprehensive overview of patent activities in India, including publications, examinations, grants,...
Read more about Indian Patent Statistics Report – 2023